The interregnum of nuclear transcription between meiotic maturation in oocytes and activation of the embryonic genome ensures critical roles for pre-existing stores of RNA and proteins (
Seydoux and Braun, 2006). Through gene targeting studies, individual maternal proteins have been implicated as essential for cleavage-stage development in mouse (
Zheng and Dean, 2007). We have now identified a MDa complex of proteins composed of at least four components (FLOPED, MATER, TLE6, Filia) located in the subcortex of eggs and required for pre-implantation mouse development. Although the absence of the SCMC significantly impedes development beyond the two-cell embryo, it seems likely that defects arise earlier as progression from one- to two-cells is delayed and the initial cell division is often asymmetrical. This could result from abnormalities in syngamy, mitotic spindle formation, cytokinesis or cell cycle progression and could affect later events in embryonic development including axes formation, a subject of intense investigative interest (
Rossant and Tam, 2004;
Motosugi et al., 2005;
Louvet-Vallee et al., 2005;
Kurotaki et al., 2007;
Bischoff et al., 2008).
Although genetic ablation of either
Floped or
Mater (or both) does not materially affect intraovarian folliculogenesis, ovulation or fertilization, the failure of mutant embryos to complete cleavage stage development results in a striking female sterile phenotype. FLOPED is the smallest (18 kDa, 164 amino acids) component, but its absence disrupts complex formation as effectively as MATER, the largest (125 kDa, 1163 amino acids). Genetic ablation of the genes encoding Filia (38 kDa, 346 amino acids) and of TLE6 (65 kDa, 581 amino acids) has not been reported. Three of the proteins have motifs associated with protein-protein interactions: MATER has 13 leucine-rich repeats (
Kobe and Kajava, 2001) near its carboxyl terminus; TLE6 has 5 WD (~31 amino acid tryptophan-aspartate) repeats (
Li and Roberts, 2001); and Filia has a novel 23 amino acid 10 fold repeat not described in other proteins. FLOPED contains a single ~70 amino acid KH (hnRNA K homology) domain, multimers of which associate with single-strand (RNA or DNA) nucleic acid (
Valverde et al., 2008).
The SCMC has an M
r between 669 and 2000 kDa that is considerably in excess of the total mass (~250 kDa) of the four identified proteins. In addition, FLOPED, MATER, TLE6 or Filia (by themselves or paired with each other) fail to localize to the subcortex in heterologous cells (data not shown) which suggests the presence of additional components to anchor the SCMC near the membrane. In the current studies, PADI6 was identified by tandem mass spectrometry after immunoprecipitation with anti-FLOPED antibodies (6 peptides, 11% coverage).
Padi6 encodes an oocyte-specific, 77 kDa peptidylarginine deiminase that is preferentially located in the cortex of eggs and preimplantation embryos (
Wright et al., 2003).
Padi6tm/tm females ovulate eggs that can be fertilized, but do not progress beyond cleavage stage embryogenesis and females are sterile (
Esposito et al., 2007). Similar to embryos derived from
Mater null females (
Tong et al., 2000), embryos from
Padi6 null females have impaired embryonic transcription and dysregulation of protein translation (
Yurttas et al., 2008), a recapitulation which implicate PADI6 as a fifth member of the SCMC. The enzymatic activity of peptidylarginine deiminase converts arginine to citrulline in proteins and clarification of its role in early embryogenesis should provide additional insights into the role of the SCMC in early development.
The expression of the genes that encode at least four of these proteins (
Floped,
Mater,
Tle6,
Padi6) is regulated by FIGLA (
Factor
in the
germ
line,
alpha), a bHLH transcription factor. A role in activation of
Filia remains indeterminate as transcripts were not represented in the screened microarrays and SAGE libraries used to identify potential downstream targets (
Joshi et al., 2007). FIGLA was initially implicated as a transcription factor in the coordinate expression of the zona pellucida genes (
Zp1,
Zp2,
Zp3) that encode three proteins that form an extracellular matrix surrounding eggs and pre-implantation embryos. Each zona gene contains a canonical E-box (CANNTG) within 250 bp of its transcription start site which when ablated affects reporter gene expression in heterologous cells (
Liang et al., 1997). Zona transcripts were more abundant in normal than in
Figla null ovaries (
Soyal et al., 2000;
Joshi et al., 2007). Thus, it appears that FIGLA regulates at least two multi-component complexes critical for early development, the extracellular zona pellucida and the intracellular SCMC. As observed with other tissue-specific bHLH master regulators (e.g. myoD,
Tapscott, 2005), it is likely that FIGLA does not act in isolation and that other transcription factors are critical modulators of genetic hierarchies required for successful fertilization and the onset of development. Recently, heterozygous mutation of
Figla have been observed in two patients with premature ovarian failure (
Zhao et al., 2008) raising the possibility that genetic pathways affected by FIGLA are causal in disease.
Impaired progression beyond the first embryonic cleavage has been observed in a number of experimental settings including defects in cell cycle, cytokinesis, and activation of the embryonic genome. Maternal ablation of the
Brg1 (official name:
Smarca4), the catalytic subunit of SWI/SNF remodeling complex (
Bultman et al., 2006) or of
Ube2a, a ubiquitin-conjugating DNA repair enzyme (
Roest et al., 2004), effectively arrests development at two-cells as does treatment with α-amanitin, an inhibitor of RNA polymerase (
Golbus et al., 1973;
Warner and Versteegh, 1974;
Flach et al., 1982). Embryos derived from
Matertm/tm and
Padi6tm/tm females also have a pronounced decrease in de novo transcription in two-cell embryos (
Tong et al., 2000;
Yurttas et al., 2008) which raises the possibility that the SCMC plays a role in activation of the embryonic genome. However, it remains perplexing how a subcortical complex would affect nuclear events, although disruption of TCL1 (T cell leukemia/lymphoma 1) mediated shuttling of Akt (protein kinase B) into the nucleus inhibits embryonic progression (
Narducci et al., 2002;
Pekarsky et al., 2000). Perhaps more likely, the observed decrease in transcription and deregulation of translation reflects impeding death of early embryos derived from
Mater and
Padi6 null females. To further investigate the role of SMCM in cell cycle progression and cytokinesis, we are establishing suitable reagents for in vivo investigations using time-lapse confocal microscopy.
The persistence of the SCMC in the early blastocyst raises the possibility of a role(s) beyond ensuring embryonic progression through cleavage stage development. Following the third cell division, the blastomeres compact to form the morula and individual embryonic cells are polarized with the SCMC remaining at the apical cortex. Subsequent cell division, orthogonal to the axis of polarity results in ‘outer’ cells that contain the SCMC and ‘inner’ cells that do not. Outer cells contribute progeny to the trophectoderm (precursor to the placenta) whereas ‘inner’ cells form the embryonic inner cell mass (
Tarkowski and Wroblewska, 1967;
Johnson and Ziomek, 1981). The plasticity in the reformation of the SCMC in ‘inner cells’ after release from cell-cell contacts may reflect the regulative nature of early mouse embryogenesis. Embryos lacking TEAD4 do not form a trophectoderm (
Yagi et al., 2007;
Nishioka et al., 2008) and the persistence of the SCMC in the outer cells of E3.5
Tead4 null embryos indicates that topology rather than cell lineage determines the presence of the complex. Thus, the SCMC does not appear to be sufficient to establish trophectoderm lineage.
Other maternal proteins adopt a polarized location during pre-implantation development, some as early as the two-cell stage including TCL1 and UCH-L1 (ubiquitin carboxylterminal hydrolase L1). Although
Tcl1 and
Uchl1 homozygous null female are fertile, both have marked decreases in fecundity with litter sizes about half the number of normal (
Narducci et al., 2002;
Sekiguchi et al., 2006). Additional embryonic proteins such as EZRIN and PAR3/aPKC also become polarized, albeit not until the 8-cell stage of embryogenesis.
Ezr null mice die perinatally (
Saotome et al., 2004) and EZRIN is an early marker of blastomere polarization and of trophoblast precursor cells (
Louvet et al., 1996;
Dard et al., 2001). The PAR3/aPKC complex is asymmetrically located in the 8-cell embryo and experimental disruption of either protein in individual blastomeres in vitro, partially redirects their cell fate toward that of an ‘inner’ cell after the fourth embryonic cleavage (
Plusa et al., 2005). Whether these proteins interact with the SCMC beginning at the 8-cell stage of development has not been ascertained, but their apical localization occurs after the initial formation of the complex.
In earlier screens looking for oocyte-specific proteins, 2410146L05Rik (FLOPED) was identified as cat, dog or mouse oocyte expressed protein (C/D/MOEP) and proposed as an RNA binding proteins based on the presence of a KH domain (
Pierre et al., 2007;
Herr et al., 2008). However, staining RNA in normal embryos with acridine orange did not co-localize with the SCMC and treatment with RNase did not disrupt the complex as determined by immunoprecipitation (data not shown). Nevertheless, specific transcripts could bind to the SCMC and given the prominent role of RNA localization in development (
Strome and Lehmann, 2007), this possibility warrants further investigation. Human homologues can be identified for FLOPED (149 amino acids, 39% identity), MATER (1200 amino acids, 46% identity), TLE6 (449 amino acids, 44% identity), Filia (217 amino acids, 41% identity) and PADI6 (694 amino acids, 67% identity). Thus, further elucidation of the molecular role of the SCMC in the arrested development observed with embryos derived from
Flopedtm/tm and
Matertm/tm female mice may provide insights into clinical infertility or recurrent spontaneous abortion.